Invesco’s abrdn Healthcare Investors HQH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2M | Buy |
112,540
+2,376
| +2% | +$44.9K | ﹤0.01% | 2541 |
|
|
2025
Q4 | $2.09M | Buy |
110,164
+16,713
| +18% | +$316K | ﹤0.01% | 2592 |
|
|
2025
Q3 | $1.73M | Buy |
93,451
+19,283
| +26% | +$315K | ﹤0.01% | 2676 |
|
|
2025
Q2 | $1.15M | Buy |
74,168
+27,768
| +60% | +$430K | ﹤0.01% | 2790 |
|
|
2025
Q1 | $754K | Buy |
46,400
+16,417
| +55% | +$282K | ﹤0.01% | 2960 |
|
|
2024
Q4 | $481K | Buy |
29,983
+1,884
| +7% | +$33.4K | ﹤0.01% | 3247 |
|
|
2024
Q3 | $523K | Buy |
28,099
+2,187
| +8% | +$40.8K | ﹤0.01% | 3217 |
|
|
2024
Q2 | $452K | Sell |
25,912
-14,085
| -35% | -$235K | ﹤0.01% | 3312 |
|
|
2024
Q1 | $674K | Sell |
39,997
-3,568
| -8% | -$60.8K | ﹤0.01% | 3187 |
|
|
2023
Q4 | $722K | Buy |
43,565
+964
| +2% | +$14.8K | ﹤0.01% | 3039 |
|
|
2023
Q3 | $662K | Buy |
42,601
+3,861
| +10% | +$64.4K | ﹤0.01% | 3063 |
|
|
2023
Q2 | $661K | Sell |
38,740
-10,467
| -21% | -$181K | ﹤0.01% | 3103 |
|
|
2023
Q1 | $869K | Buy |
49,207
+19,037
| +63% | +$346K | ﹤0.01% | 2962 |
|
|
2022
Q4 | $543K | Buy |
30,170
+9,280
| +44% | +$172K | ﹤0.01% | 3221 |
|
|
2022
Q3 | $361K | Sell |
20,890
-355
| -2% | -$6.79K | ﹤0.01% | 3424 |
|
|
2022
Q2 | $397K | Buy |
21,245
+4,035
| +23% | +$79.8K | ﹤0.01% | 3442 |
|
|
2022
Q1 | $357K | Buy |
17,210
+4,507
| +35% | +$95.7K | ﹤0.01% | 3560 |
|
|
2021
Q4 | $302K | Sell |
12,703
-18,331
| -59% | -$457K | ﹤0.01% | 3612 |
|
|
2021
Q3 | $794K | Buy |
31,034
+1,479
| +5% | +$38.9K | ﹤0.01% | 3215 |
|
|
2021
Q2 | $760K | Sell |
29,555
-5,163
| -15% | -$127K | ﹤0.01% | 3249 |
|
|
2021
Q1 | $847K | Sell |
34,718
-4,222
| -11% | -$103K | ﹤0.01% | 3109 |
|
|
2020
Q4 | $928K | Sell |
38,940
-34,824
| -47% | -$757K | ﹤0.01% | 2964 |
|
|
2020
Q3 | $1.52M | Sell |
73,764
-2,296
| -3% | -$48.5K | ﹤0.01% | 2616 |
|
|
2020
Q2 | $1.62M | Sell |
76,060
-5,301
| -7% | -$108K | ﹤0.01% | 2567 |
|
|
2020
Q1 | $1.45M | Buy |
81,361
+6,754
| +9% | +$133K | ﹤0.01% | 2564 |
|
|
2019
Q4 | $1.56M | Buy |
74,607
+9,011
| +14% | +$178K | ﹤0.01% | 2755 |
|
|
2019
Q3 | $1.2M | Buy |
65,596
+6,304
| +11% | +$122K | ﹤0.01% | 2898 |
|
|
2019
Q2 | $1.19M | Buy |
59,292
+13,681
| +30% | +$270K | ﹤0.01% | 2971 |
|
|
2019
Q1 | $937K | Buy |
45,611
+8,379
| +23% | +$171K | ﹤0.01% | 3057 |
|
|
2018
Q4 | $668K | Buy |
37,232
+15,377
| +70% | +$315K | ﹤0.01% | 3158 |
|
|
2018
Q3 | $506K | Sell |
21,855
-838
| -4% | -$19K | ﹤0.01% | 3426 |
|
|
2018
Q2 | $488K | Sell |
22,693
-461
| -2% | -$9.81K | ﹤0.01% | 3432 |
|
|
2018
Q1 | $499K | Buy |
23,154
+6,127
| +36% | +$141K | ﹤0.01% | 3329 |
|
|
2017
Q4 | $384K | Buy |
17,027
+4,140
| +32% | +$96.9K | ﹤0.01% | 3384 |
|
|
2017
Q3 | $325K | Buy |
+12,887
| New | +$324K | ﹤0.01% | 3429 |
|
|
2016
Q3 | – | Sell |
-8,993
| Closed | -$211K | – | 3662 |
|
|
2016
Q2 | $211K | Buy |
8,993
+25
| +0.3% | +$620 | ﹤0.01% | 3519 |
|
|
2016
Q1 | $215K | Buy |
+8,968
| New | +$213K | ﹤0.01% | 3544 |
|
Other funds holding HQH
PCM
AAM
NIM
ZCP
Invesco's HQH Position: Q1 2026 in Review
Invesco increased its abrdn Healthcare Investors (HQH) stake by 2.2% in Q1 2026, buying an estimated $44.9K and bringing the position to 112,540 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #2541.
Invesco first reported a position in HQH in Q1 2016 and has held it in 37 quarters since. The position peaked at $2.09M in Q4 2025. 128 funds tracked by Wall St. Rank hold HQH as of Q1 2026.
- Invesco held 112,540 shares of abrdn Healthcare Investors worth $2M as of Q1 2026.
- Invesco bought 2,376 abrdn Healthcare Investors shares in Q1 2026, an estimated $44.9K.
- abrdn Healthcare Investors made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #2541 holding.
- Invesco first reported a position in abrdn Healthcare Investors in Q1 2016 and has held it in 37 quarters since.
- Invesco's abrdn Healthcare Investors position peaked at $2.09M in Q4 2025.
- 128 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.